This article in Psychiatric Times reviews some interesting research which suggests that drugs which modulate the estrogen receptor may improve cognitive functioning in patients with schizophrenia. Â This is the first study to show that oral [...]
Which treatment is best for managing menopausal sleep problems? We tend to think of estrogen replacement therapy as being the best option for all menopausal symptoms; however, there are other options for managing menopausal symptoms, [...]
Because women appear to be at increased risk for new onset and recurrent depression as they transition into the menopause, it has been hypothesized that declining ovarian function -- or estrogen "withdrawal" -- may trigger [...]
Nearly a third of postmenopausal women experience vaginal changes, including dryness, itching and pain during sex -- symptoms related to the declining levels of estrogen occurring during the transition to menopause. Â According to a study [...]
In healthy perimenopausal women with hot flashes, treatment with both estradiol and venlafaxine resulted in significantly greater improvement in quality of life, as compared to placebo. Estradiol had beneficial treatment effects on all domains of the [...]
Women with bipolar disorder often experience fluctuating mood symptoms across the menstrual cycle, typically reporting an exacerbation of symptoms during the premenstrual phase of the cycle (Rasgon et al, 2003, 2005). Â Other studies have indicated [...]
Several years ago, we reviewed a paper suggesting that estrogen may be a beneficial treatment for women with schizophrenia. Â In this study, patients with schizophrenia were treated with estrogen. Â There was significant improvement in their [...]
Early observational studies suggested that postmenopausal hormone treatment may improve cognitive functioning in women; however, studies from the Women’s Health Initiative have shown that estrogen replacement therapy started in postmenopausal women (65 years or older) [...]
While there are concerns regarding the risks associated with prolonged use of hormone replacement, an increasing number of studies suggest that the risk may be relatively low in certain settings. A study presented this week at the Endocrine Society’s annual meeting which analyzed data from 43 randomized clinical trials suggests that menopausal hormone-replacement therapy does not appear to affect mortality either positively or negatively.
Here's a new way to look at hot flashes. How much do they cost our society in terms of additional health care and lost productivity?
